Načítá se...
Mesenchymal stromal cells for treatment of the acute respiratory distress syndrome: The beginning of the story
In spite of decades of research, the acute respiratory distress syndrome (ARDS) continues to have an unacceptably high mortality and morbidity. Mesenchymal stromal cells (MSCs) present a promising candidate for the treatment of this condition and have demonstrated benefit in preclinical models. MSCs...
Uloženo v:
| Vydáno v: | J Intensive Care Soc |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
SAGE Publications
2015
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5606462/ https://ncbi.nlm.nih.gov/pubmed/28979439 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1751143715586420 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|